Trial ID or NCT#



recruiting iconRECRUITING


The Kids-DOTT trial is a randomized controlled clinical trial whose primary objective is to evaluate non-inferiority of shortened-duration (6 weeks) versus conventional-duration (3 months) anticoagulation in children with first-episode acute venous thrombosis. The first stage of the trial has consisted of a pilot/feasibility component, which then continues as the definitively-powered trial.

Official Title

Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children

Eligibility Criteria

Ages Eligible for Study: Younger than 20 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


John D. Louie, MD
John D. Louie, MD
Interventional radiologist
Clinical Associate Professor, Radiology
Robert Lowsky
Robert Lowsky
Blood and marrow transplant specialist, Hematologist, Blood and marrow transplant specialist
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy) at the Stanford University Medical Center
Clara Lo

Contact us to find out if this trial is right for you.


Elaine Macasiray